Addressing heart failure must be considered a global health priority because poor awareness of the disease leads to many premature deaths. Approximately 26 million people are living with heart failure worldwide, and if current trends continue the disease will impose ever-increasing burdens on patients, caregivers and healthcare systems.
July 10, 2023
Oxford PharmaGenesis wins prestigious King's Award
We were honoured on Friday as King Charles III’s representative in Oxfordshire, Lord-Lieutenant Marjorie Glasgow BEM, presented our HealthScience Communications Consultancy with a 2023 King’s Award at our head office just outside Oxford, UK.
For Oxford PharmaGenesis, this completes a remarkable hat-trick, having secured the Queen’s Award for Enterprise in 2015 and in 2019.
Recent announcements regarding Government investments in Oxfordshire are good news for those working within biosciences in the county.